PharmaShots | Incisive News in 3 Shots

Subscribe Now

satralizumab-mwge

Genentech to Present New Data of Enspryng (satralizumab-mwge) for Neuromyelitis Optica Spectrum Disorder at MSVirtual2020

Genentech to Present New Data of Enspryng (satralizumab-mwge) for Neuromyelitis Optica Spectrum Disorder at MSVirtual2020

September 10, 2020

Roche's Enspryng (satralizumab-mwge) Receives the US FDA's Approval for Neuromyelitis Optica Spectrum Disorder

Roche's Enspryng (satralizumab-mwge) Receives the US FDA's Approval for Neuromyelitis Optica Spectrum Disorder

August 17, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us